|
||
|
Leads generated from QSAR and docking studies (compounds 1, 7, 9, 13, 19) structural stability analysis upon ligand docking. |
|
||||||||
| Part of: Sivakumar B, Kaliappan I (2023) Lead drug discovery from imidazolinone derivatives with Aurora kinase inhibitors. Pharmacia 70(4): 1529-1540. https://doi.org/10.3897/pharmacia.70.e114935 |